Financial

Relatively High EPS Growth Detected in Shares of RTI Biologics in the Health Care Supplies Industry

Dec 27, 2010 (SmarTrend(R) News Watch via COMTEX) — Below are the top 5 companies in the Health Care Supplies industry ranked by the year-over-year expected EPS growth rate. The long-term growth rate is the expected annual increase in operating EPS over the next three to five years.

RTI Biologics (RTIX) EPS is expected to grow 66.7% year-over-year, better than the company’s long-term growth rate of 16%. Based on the forward P/E of 25.9x its PEG ratio is 1.62, which signifies a premium valuation given for growth.

Synergetics USA (SURG) EPS is expected to grow 50% year-over-year, better than the company’s long-term growth rate of 20%. Based on the forward P/E of 13.1x its PEG ratio is 0.66, which signifies a discount in value relative to growth.

Cooper Cos (COO) EPS is expected to grow 37.7% year-over-year, better than the company’s long-term growth rate of 14%. Based on the forward P/E of 16.4x its PEG ratio is 1.17, which signifies a premium valuation given for growth.

Neogen (NEOG) EPS is expected to grow 29% year-over-year, better than the company’s long-term growth rate of 22.5%. Based on the forward P/E of 43.3x its PEG ratio is 1.92, which signifies a premium valuation given for growth.

Vascular Solutions (VASC) EPS is expected to grow 23% year-over-year, better than the company’s long-term growth rate of 17.5%. Based on the forward P/E of 31.7x its PEG ratio is 1.81, which signifies a premium valuation given for growth.

SmarTrend currently has shares of Synergetics USA in an Uptrend and issued the Uptrend alert on August 17, 2009 at $1.49. The stock has risen 177.2% since the Uptrend alert was issued.

Write to Chip Brian at cbrian@tradethetrend.com

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button